Back to Search
JULIET EMAMAULLEE, M.D., PH.D.
M.D., PH.D.
Transplant Surgery Physician
NPI: 1437475563IndividualAccepts Medicare
Specialties, Licenses & Credentials
Transplant Surgery PhysicianPrimary
Transplant Surgery
Code: 204F00000X
340407(NY)A150691(CA)
CMS Specialties
PrimaryGENERAL SURGERY
Education
OTHER
Class of 2010
Research & Publications (20)
Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.
PMID 19289457·Diabetes·2009
7-preclinical
Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation.
PMID 18713144·Transpl Int·2009
8-other
Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats.
PMID 19136892·Transplantation·2009
7-preclinical
Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide.
PMID 19131571·Endocrinology·2009
7-preclinical
Costimulatory blockade with belatacept in clinical and experimental transplantation - a review.
PMID 19426116·Expert Opin Biol Ther·2009
6-review
AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice.
PMID 19301207·Autoimmunity·2009
7-preclinical
The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice.
PMID 18356409·Diabetes·2008
7-preclinical
The role of macrophage migration inhibitory factor in mouse islet transplantation.
PMID 19034004·Transplantation·2008
7-preclinical
The role of macrophage migration inhibitory factor on glucose metabolism and diabetes.
PMID 18612626·Diabetologia·2008
6-review
Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.
PMID 18511515·Endocrinology·2008
7-preclinical
Belatacept and basiliximab diminish human antiporcine xenoreactivity and synergize to inhibit alloimmunity.
PMID 18192921·Transplantation·2008
7-preclinical
Human islet function is not impaired by the sphingosine-1-phosphate receptor modulator FTY720.
PMID 17617868·Am J Transplant·2007
7-preclinical
Factors influencing the loss of beta-cell mass in islet transplantation.
PMID 17436849·Cell Transplant·2007
6-review
Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.
PMID 17303806·Diabetes·2007
7-preclinical
Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis.
PMID 17038911·Transplantation·2006
7-preclinical
Interventional strategies to prevent beta-cell apoptosis in islet transplantation.
PMID 16804057·Diabetes·2006
6-review
XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes.
PMID 16123341·Diabetes·2005
7-preclinical
XIAP overexpression in islet beta-cells enhances engraftment and minimizes hypoxia-reperfusion injury.
PMID 15888033·Am J Transplant·2005
6-review
The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin.
PMID 11472024·J Biol Inorg Chem·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE
ROCHESTER, NY 14642 - Phone
- (585) 273-3881
Quick Facts
- NPI
- 1437475563
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile